Skip to main content

Ionis to present at upcoming investor conferences

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

  • 24th Annual Needham Virtual Healthcare Conference on Monday, April 7, 2025
  • Bank of America 2025 Health Care Conference on Wednesday, May 14, 2025
  • 2025 RBC Capital Markets Global Healthcare Conference on Wednesday, May 21, 2025

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals

For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has six marketed medicines and a leading pipeline in neurology, cardiology and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter), LinkedIn and Instagram.

Contacts

Ionis Pharmaceuticals Investor Contact:

D. Wade Walke, Ph.D. – ir@ionis.com760-603-2331



Ionis Pharmaceuticals Media Contact:

Hayley Soffer – media@ionis.com – 760-603-4679

Recent Quotes

View More
Symbol Price Change (%)
AMZN  212.79
+3.02 (1.44%)
AAPL  258.86
+2.94 (1.15%)
AMD  220.18
+2.68 (1.23%)
BAC  50.06
+0.68 (1.38%)
GOOG  297.66
+3.20 (1.09%)
META  573.02
-1.44 (-0.25%)
MSFT  372.88
-0.58 (-0.16%)
NVDA  177.64
+0.25 (0.14%)
ORCL  145.54
-0.84 (-0.57%)
TSLA  352.82
-7.77 (-2.15%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.